JP2005519914A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519914A5 JP2005519914A5 JP2003562156A JP2003562156A JP2005519914A5 JP 2005519914 A5 JP2005519914 A5 JP 2005519914A5 JP 2003562156 A JP2003562156 A JP 2003562156A JP 2003562156 A JP2003562156 A JP 2003562156A JP 2005519914 A5 JP2005519914 A5 JP 2005519914A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gag
- peptide complex
- salt
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 10
- 208000035404 Autolysis Diseases 0.000 claims 3
- 206010057248 Cell death Diseases 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 230000028043 self proteolysis Effects 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 239000008346 aqueous phase Substances 0.000 claims 2
- 210000002808 connective tissue Anatomy 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000002797 proteolythic effect Effects 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS0112A AUPS011202A0 (en) | 2002-01-23 | 2002-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| AUPS1054A AUPS105402A0 (en) | 2002-03-12 | 2002-03-12 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| PCT/AU2003/000061 WO2003062279A1 (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519914A JP2005519914A (ja) | 2005-07-07 |
| JP2005519914A5 true JP2005519914A5 (https=) | 2006-03-09 |
Family
ID=27614006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003562156A Pending JP2005519914A (ja) | 2002-01-23 | 2003-01-23 | 結合組織の治療、防御および回復のためのニュートラシューティカルズ（ｎｕｔｒａｃｅｕｔｉｃａｌｓ） |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7371820B2 (https=) |
| EP (1) | EP1476471A4 (https=) |
| JP (1) | JP2005519914A (https=) |
| AU (1) | AU2003201402B2 (https=) |
| CA (1) | CA2474269A1 (https=) |
| NZ (1) | NZ534760A (https=) |
| WO (1) | WO2003062279A1 (https=) |
| ZA (2) | ZA200506610B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| AU2003903037A0 (en) * | 2003-06-17 | 2003-07-03 | Institute Of Nutraceutical Research | Connective tissue derived polypeptides |
| US20080200372A1 (en) * | 2004-01-16 | 2008-08-21 | Institute Of Nutraceutical Research Pty Ltd. | Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| AU2005202062B2 (en) * | 2005-01-14 | 2012-08-16 | Institute Of Nutraceutical Research Pty Ltd | Nutraceuticals for the treatment, protection, and restoration of connective tissues |
| JP4955944B2 (ja) * | 2005-06-30 | 2012-06-20 | 丸共バイオフーズ株式会社 | コンドロイチン硫酸カルシウム及びその製造方法 |
| US7943764B2 (en) * | 2005-10-27 | 2011-05-17 | Dimitry Alekseevich Savaschuk | Method for producing sulphated glycosaminoglycans from biological tissues |
| US20080279825A1 (en) * | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
| FR2918376B1 (fr) * | 2007-07-04 | 2011-10-28 | Mathieu Borge | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage |
| JP5143621B2 (ja) * | 2008-05-08 | 2013-02-13 | 電気化学工業株式会社 | 哺乳動物由来の生体液試料中のヒアルロン酸の分子量分布の測定方法 |
| FR2938762B1 (fr) * | 2008-11-21 | 2011-02-04 | Oreal | Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee |
| WO2016111899A1 (en) | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating lung disorders |
| WO2016111900A1 (en) * | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating arthritis |
| JP2018515485A (ja) * | 2015-05-01 | 2018-06-14 | ザ プロクター アンド ギャンブル カンパニー | 皮膚の外観を改善する方法及びニコチンアミドリボシドを使用したそのための組成物 |
| WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
| EP3236928B1 (en) | 2016-01-11 | 2020-12-09 | The Procter and Gamble Company | Method of treating a skin condition and compositions therefor |
| US10993969B2 (en) | 2016-02-05 | 2021-05-04 | Gary M. Petrucci | Methods and materials for treating nerve injuries and neurological disorders |
| US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
| CN110785161B (zh) | 2017-06-23 | 2023-06-20 | 宝洁公司 | 用于改善皮肤外观的组合物和方法 |
| US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
| CN112437657A (zh) | 2018-07-03 | 2021-03-02 | 宝洁公司 | 处理皮肤状况的方法 |
| CN111235202B (zh) * | 2018-11-29 | 2022-03-08 | 中国中医科学院医学实验中心 | 一种鹿骨蛋白质提取物及其制备方法与应用 |
| JP7590462B2 (ja) | 2020-06-01 | 2024-11-26 | ザ プロクター アンド ギャンブル カンパニー | ビタミンｂ３化合物の皮膚への浸透を改善する方法 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN113603762B (zh) * | 2021-08-20 | 2023-06-27 | 吉林农业大学 | 一种花马杂交鹿鹿角盘活性肽及其制备方法和应用 |
| ES2956802B2 (es) * | 2022-05-20 | 2025-10-02 | Bioiberica S A U | Hidrogeles para su uso en ingenieria de tejidos de la piel |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE857389A (fr) * | 1977-08-02 | 1977-12-01 | Marbex Finance Ltd | Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000 |
| CA1302880C (en) | 1986-07-25 | 1992-06-09 | Peter Koepff | Agents for the treatment of arthroses |
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| US6136793A (en) * | 1992-02-20 | 2000-10-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| JP3248170B2 (ja) * | 1992-12-11 | 2002-01-21 | マルハ株式会社 | コンドロイチン硫酸蛋白複合体含有食品 |
| US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
| EP0873128B1 (en) * | 1996-01-11 | 2004-11-17 | Jagotec Ag | Oral administration of effective amounts of forms of hyaluronic acid |
| TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| WO1999001143A1 (en) * | 1997-07-03 | 1999-01-14 | Orquest, Inc. | Cross-linked polysaccharide drug carrier |
| US6025327A (en) | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
| US5922692A (en) * | 1998-03-11 | 1999-07-13 | Marino; Richard P. | Concentration of glycosaminoglycans and precursors thereto in food products |
| US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
| JP3271008B2 (ja) * | 1999-11-18 | 2002-04-02 | 独立行政法人産業技術総合研究所 | コンドロイチン硫酸類の製造方法 |
| DE10008896A1 (de) * | 2000-02-25 | 2001-08-30 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolderivaten und Alkylnaphthalaten |
| HUP0302396A2 (hu) * | 2000-05-05 | 2003-10-28 | Gtc Biotherapeutics, Inc. | Transzgénikus úton előállított dekorin |
| US6924273B2 (en) * | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
-
2003
- 2003-01-23 CA CA002474269A patent/CA2474269A1/en not_active Abandoned
- 2003-01-23 NZ NZ534760A patent/NZ534760A/xx not_active IP Right Cessation
- 2003-01-23 WO PCT/AU2003/000061 patent/WO2003062279A1/en not_active Ceased
- 2003-01-23 ZA ZA200506610A patent/ZA200506610B/en unknown
- 2003-01-23 AU AU2003201402A patent/AU2003201402B2/en not_active Ceased
- 2003-01-23 JP JP2003562156A patent/JP2005519914A/ja active Pending
- 2003-01-23 EP EP03700092A patent/EP1476471A4/en not_active Withdrawn
-
2004
- 2004-07-22 US US10/896,546 patent/US7371820B2/en not_active Expired - Fee Related
- 2004-08-19 ZA ZA200406621A patent/ZA200406621B/en unknown
-
2005
- 2005-05-16 US US11/130,470 patent/US7211648B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519914A5 (https=) | ||
| JP2019504881A5 (https=) | ||
| JP2006149406A5 (https=) | ||
| JP2001524320A5 (https=) | ||
| JP2008508859A5 (https=) | ||
| JP2004521653A5 (https=) | ||
| JP2004536077A5 (https=) | ||
| JP2002503484A5 (https=) | ||
| JP2001522783A5 (https=) | ||
| CA2523844A1 (en) | Stable thrombin composition | |
| CN105567775A (zh) | 鱼胶原肽螯合钙的生产方法 | |
| JP2005532986A5 (https=) | ||
| JP2021505620A5 (https=) | ||
| JP2015535237A5 (https=) | ||
| TWI633889B (zh) | 具有溶栓、抗栓和自由基清除三重活性的化合物，以及藥物組合物及其用途 | |
| JP2003089647A5 (https=) | ||
| JP2009120512A (ja) | 関節軟骨再生促進剤 | |
| JP2009500045A5 (https=) | ||
| JP5778692B2 (ja) | 疾病抑制剤 | |
| JP2007533298A5 (https=) | ||
| JP2737790B2 (ja) | 絹タンパク質加水分解物含有食物およびその製造方法 | |
| JP2004534073A5 (https=) | ||
| ES2309328T3 (es) | Inhibidores de factor de coagulacion xa, produccion y utilizacion de los mismos. | |
| HRP20120502T1 (hr) | Farmaceutske smjese s poboljšanim profilom otapanja za slabo topljive lijekove | |
| JP2003522782A5 (https=) |